We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SIBIA Neurosciences (SIBI) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (474)8/3/1999 1:19:00 AM
From: Miljenko Zuanic  Respond to of 579

Congret on SIBI. It is not what we were hoping for.
WE (I) didn't got rich with SIBI investment (yes, I bought SIBI two weeks ago for first time, solely based on patents value), bat I am richer in several way:

1. I met nice man who is now my friend
2. I learned a lot from him
3. The SI boards will be much different without you (I do not want to offend anyone).

No money can pay this, and even if I lost my investment on SIBI I won't blink eyes and won't change this my statements.

Wish that we are closed and can spent few hours together over few pitcher of beers (normally with other SI bio-freaks).



PS: Yes, I owned AGPH for certain period (sold on day when their PI was recommended for approval). Also did own CNTO (thanks to Peter) but sold before J&J acquisition. Regards the AZA, I was on the way to buy on last deep, but didn't want to cut short portion allocated for ALKS. So, I am not pretending that am brave or smart because of this coincidence with recent acquisitions.
Actually it make me sad and worry (except NXTR-GILD merge), because now is issue to pick good company which will not be munched prematurely. And this is much harder than speculate who may be for sale. SIBI was surprise, but more surprised are now PFE and few others pharma and bios, as they have to worry under which terms MRK will license (if at all) SIBI patents.